LugerT, PaulC. Potential new indications of topical calcineurin inhibitors. Dermatology, 2007; 215Suppl 1:45-.
2.
YangCH, SmithTJ, HongJ-Y. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res, 1994; 54:1982S-6S.
3.
BickersDR, AtharM. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol, 2006; 126:2565-75.
4.
UtechtKN, HilesJJ, KolesarJ. Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors. Am J Health Syst Pharm, 2006; 63:2340-8.
5.
KöfelerHC, FaulerG, WindischhoferW, LeisHJ. Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation. Br J Pharmacol, 2000; 130:1241-6.
6.
HighAIV, FitzpatrickJE. Topical antifungal agents. In: WolffK, GoldsmithLA, KatzSI, et al, editors. Fitzpatrick's dermatology in general medicine. 7th ed., Columbus: McGraw-Hill; United States, 2008. p. 2116.